Co-Authors
This is a "connection" page, showing publications co-authored by Frank Kirchhoff and Janis Müller.
Connection Strength
1.879
-
Reduced Susceptibility to VIRIP-Based HIV-1 Entry Inhibitors Has a High Genetic Barrier and Severe Fitness Costs. J Virol. 2018 09 01; 92(17).
Score: 0.782
-
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro. Nat Commun. 2021 07 28; 12(1):4584.
Score: 0.240
-
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab. 2021 02; 3(2):149-165.
Score: 0.232
-
Peptide and peptide-based inhibitors of SARS-CoV-2 entry. Adv Drug Deliv Rev. 2020 12; 167:47-65.
Score: 0.228
-
SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans. mBio. 2020 10 16; 11(5).
Score: 0.227
-
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection. Nat Commun. 2021 03 19; 12(1):1726.
Score: 0.058
-
Undermining breastfeeding will not alleviate the COVID-19 pandemic - Authors' reply. Lancet. 2020 10 10; 396(10257):1065-1066.
Score: 0.057
-
Detection of SARS-CoV-2 in human breastmilk. Lancet. 2020 06 06; 395(10239):1757-1758.
Score: 0.055